Skip to content
2000
Volume 19, Issue 6
  • ISSN: 1381-6128
  • E-ISSN: 1873-4286

Abstract

Human neutrophil proteinase 3 (PR3) and elastase (HNE) are homologous serine proteinases involved in the proteolytic events associated with inflammation and infection. Their close structural and functional resemblance makes it difficult to understand their respective biological functions. Thus, all natural inhibitors of PR3 identified to date preferentially target HNE, and only recently have inhibitors that target PR3 selectively been described. This review describes how differences in the structures of the extended active sites of PR3 and HNE can be exploited to produce selective inhibitors of PR3.

Loading

Article metrics loading...

/content/journals/cpd/10.2174/1381612811319060002
2013-02-01
2025-04-22
Loading full text...

Full text loading...

/content/journals/cpd/10.2174/1381612811319060002
Loading

  • Article Type:
    Research Article
Keyword(s): azapeptide; drug development; neutrophil; Proteinase 3 (myeloblastin); serpin
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test